Kyung Hee Institute of Regenerative Medicine (KIRM), Medical Science Research Institute, Kyung Hee University Medical Center, Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea.
Kyung Hee Institute of Regenerative Medicine (KIRM), Medical Science Research Institute, Kyung Hee University Medical Center, Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea; Department of Biomedical Science and Technology, Graduate School/East-West Medical Research Institute, Kyung Hee University, Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea.
Biochem Biophys Res Commun. 2019 Aug 6;515(4):524-530. doi: 10.1016/j.bbrc.2019.05.186. Epub 2019 Jun 5.
Stem cells have regenerative potentials that can be used for the treatment of critical and incurable diseases. Age-related macular degeneration (ARMD) and diabetic retinopathy are one of the most severe retinal disorders, which are mostly attributed to impairment of retinal pigmented epithelium (RPE). Thus, restoration of RPE is the main therapeutic approach to prevent the development of ocular diseases, such as ARMD. In this study, we have investigated the role of substance P (SP) on bone marrow mesenchymal stem cell (MSC)-mediated RPE regeneration in vitro. The MSCs were primed with SP followed by the addition of conditioned medium (MSC) to RPE. The effects of MSC on RPE activity was evaluated by assessing viability, proliferation rate, and migration of RPE. Ex vivo long-term culture led to altered cellular characteristics of MSCs by weakening cell viability, cytokine secretion, and differentiation potential. The conditioned medium of early passage MSC (E-MSC) enhanced the RPE viability and migration, whereas the late passage MSC (L-MSC) hardly influenced the RPE activity. SP priming, however, facilitated the inductive effects of MSC, and SP effect was more distinct in the late passage than in the early passage. Moreover, it was revealed that SP could exert its effects by modulating PDGF-BB secretion in the MSCs. Taken together, these results suggested that SP could restore the therapeutic effects of MSCs on retinal diseases by elevating their proliferative and paracrine activities through PDGF-PDGFR signaling in ex vivo culture.
干细胞具有再生潜能,可用于治疗危急和无法治愈的疾病。年龄相关性黄斑变性 (AMD) 和糖尿病性视网膜病变是最严重的视网膜疾病之一,主要归因于视网膜色素上皮 (RPE) 的损伤。因此,恢复 RPE 是预防 AMD 等眼部疾病发展的主要治疗方法。在这项研究中,我们研究了 P 物质 (SP) 在骨髓间充质干细胞 (MSC) 介导的 RPE 体外再生中的作用。将 SP 预刺激 MSC,然后将条件培养基 (MSC) 添加到 RPE 中。通过评估 RPE 的活力、增殖率和迁移来评估 MSC 对 RPE 活性的影响。体外长期培养导致 MSC 的细胞特征发生改变,表现为细胞活力、细胞因子分泌和分化潜能减弱。早期传代 MSC(E-MSC)的条件培养基增强了 RPE 的活力和迁移,而晚期传代 MSC(L-MSC)几乎不影响 RPE 活性。然而,SP 预刺激促进了 MSC 的诱导作用,晚期传代比早期传代的 SP 作用更明显。此外,研究结果表明 SP 可以通过调节 MSC 中 PDGF-BB 的分泌来发挥作用。综上所述,这些结果表明,SP 可以通过 PDGF-PDGFR 信号通路在体外培养中提高 MSC 的增殖和旁分泌活性,从而恢复 MSC 对视网膜疾病的治疗效果。